Determinants of circulating calcitriol in cardiovascular disease

• Verfasst von: Zittermann, Armin [VerfasserIn]
• Verfasst von: Zelzer, S. [VerfasserIn]
• Verfasst von: Herrmann, M. [VerfasserIn]
• Verfasst von: Gummert, J. F. [VerfasserIn]
• Verfasst von: Kleber, Marcus E. [VerfasserIn]
• Verfasst von: Trummer, C. [VerfasserIn]
• Verfasst von: Theiler-Schwetz, V. [VerfasserIn]
• Verfasst von: Keppel, M. H. [VerfasserIn]
• Verfasst von: März, Winfried [VerfasserIn]
• Verfasst von: Pilz, S. [VerfasserIn]
• Titel: Determinants of circulating calcitriol in cardiovascular disease
• Verf.angabe: A. Zittermann, S. Zelzer, M. Herrmann, J. F. Gummert, M. Kleber, C. Trummer, V. Theiler-Schwetz, M. H. Keppel, W. Maerz, S. Pilz
• E-Jahr: 2024
• Jahr: July 2024
• Umfang: 8 S.
• Fussnoten: Gesehen am 15.01.2025
• Titel Quelle: Enthalten in: The journal of steroid biochemistry and molecular biology
• Ort Quelle: New York, NY [u.a.] : Elsevier, 1990
• Jahr Quelle: 2024
• Band/Heft Quelle: 241(2024) vom: Juli, Artikel-ID 106528, Seite [1]-8
• ISSN Quelle: 1879-1220
• DOI: doi:10.1016/j.jsbmb.2024.106528
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: 25-hydroxyvitamin D
• Sach-SW: Calcitriol
• Sach-SW: Cardiovascular disease
• Sach-SW: Fibroblast growth factor-23
• Sach-SW: Regulation
• K10plus-PPN: 1914637062

Abstract

Circulating calcitriol may contribute to the risk of cardiovascular disease (CVD), but its regulation in patients with CVD is poorly characterized. We therefore aimed to assess determinants of circulating calcitriol in these patients. We analyzed 2183 independent samples from a large cohort of patients scheduled for coronary angiography and 1727 independent samples from different other cohorts from patients with a wide range of CVDs, including heart transplant candidates, to quantify the association of different parameters with circulating calcitriol. We performed univariable and multivariable linear regression analyses using the mathematical function that fitted best with circulating calcitriol. In the multivariable analysis of the large single cohort, nine parameters remained significant, explaining 30.0% (32.4% after exclusion of 22 potential outliers) of the variation in circulating calcitriol (r=0.548). Log-transformed 25-hydroxyvitamin D [25(OH)D] and log-transformed glomerular filtration rate were the strongest predictors, explaining 17.6% and 6.6%, respectively, of the variation in calcitriol. In the analysis of the combined other cohorts, including heart transplant candidates, the multivariable model explained a total of 42.6% (46.1% after exclusion of 21 potential outliers) of the variation in calcitriol (r=0.653) with log-transformed fibroblast growth factor-23 and log-transformed 25(OH)D explaining 29.0% and 6.2%, respectively. Circulating 25(OH)D was positively and FGF-23 inversely associated with circulating calcitriol. Although significant, PTH was only a weak predictor of calcitriol in both analyses (<2.5%). In patients with CVD, FGF-23 and 25(OH)D are important independent determinants of circulating calcitriol. The relative importance of these two parameters may vary according to CVD severity. Future studies should focus on the clinical importance of regulating circulating calcitriol by different parameters.